FY 2024 Federal Funding for the National Institutes of Health, including the National Institute of Child Health and Human Development (NICHD) and the National Institute for Diabetes, Digestive and Kidney Diseases (NIDDK), FY 2024 Further Consolidated Appropriations Act, HR 2882/P.L. 118-47;
FY 2025 - Federal Funding for the National Institutes of Health, including National Institute of Child Health and Human Development (NICHD) and the Office of Research on Womens Health - Report Language Submissions regarding research connected to pregnancy and pelvic organ prolapse and a research plan for epidemiology research on health disparities and pelvic floor disorders . - House and Senate Appropriations Committees.
FY 2024 Consolidated Appropriations Act, HR 4366/P.L. 118-42 - Medicare physician fee schedule conversion factor for 2024;
Discussions with House and Senate Offices regarding the future of Medicare physician payment and the Medicare physician payment fee schedule.
Duration: July 1, 2012
to
present
General Issues: Health Issues , Medicare/Medicaid
Spending: about $510,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2012: U.S. Senate, House of Representatives, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $20,000. The report was filed on April 19.
Original Filing: 301567445.xml
Lobbying Issues
FY 2024 Federal Funding for the National Institutes of Health, including the National Institute of Child Health and Human Development (NICHD) and the National Institute for Diabetes, Digestive and Kidney Diseases (NIDDK), FY 2024 Further Consolidated Appropriations Act, HR 2882/P.L. 118-47;
FY 2025 - Federal Funding for the National Institutes of Health, including National Institute of Child Health and Human Development (NICHD) and the Office of Research on Womens Health - Report Language Submissions regarding research connected to pregnancy and pelvic organ prolapse and a research plan for epidemiology research on health disparities and pelvic floor disorders . - House and Senate Appropriations Committees.
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY 2024 Consolidated Appropriations Act, HR 4366/P.L. 118-42 - Medicare physician fee schedule conversion factor for 2024;
Discussions with House and Senate Offices regarding the future of Medicare physician payment and the Medicare physician payment fee schedule.
Agencies Lobbied
U.S. Senate
4th Quarter, 2023
In Q4, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $20,000. The report was filed on Jan. 18.
Original Filing: 301528482.xml
Lobbying Issues
H.R. 6363, Further Continuing Appropriations and Other Extensions Act, 2024, which provides fiscal year 2024 appropriations to Federal agencies through January 19, 2024, Federal Funding for the National Institutes of Health, including the National Institute of Child Health and Human Development (NICHD) and the National Institute for Diabetes, Digestive and Kidney Diseases (NIDDK), Report Language Submissions regarding Precision Medicine and Urinary Incontinence and research connected to pregnancy and pelvic organ prolapse. - House and Senate Appropriations Committees.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 6363, the Further Continuing Appropriations and Other Extensions Act, 2024, which provides fiscal year 2024 appropriations to Federal agencies through January 19, 2024;
H.R. 2474, the Strengthening Medicare for Patients and Providers Act. - Meetings regarding Medicare physician payment for 2024 and beyond.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2023
In Q3, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $20,000. The report was filed on Oct. 19, 2023.
Original Filing: 301507246.xml
Lobbying Issues
FY2024 Continuing Appropriations and Other Extensions Act (through 11/17/2023) H.R. 5860, Federal Funding for the National Institutes of Health, including the National Institute of Child Health and Human Development (NICHD) and the National Institute for Diabetes, Digestive and Kidney Diseases (NIDDK), Report Language Submissions regarding Precision Medicine and Urinary Incontinence and research connected to pregnancy and pelvic organ prolapse. - House and Senate Appropriations Committees.
Agencies Lobbied
U.S. Senate
Lobbying Issues
FY2024 Continuing Appropriations and Other Extensions Act (through 11/17/2023) H.R. 5860;
H.R. 2474, the Strengthening Medicare for Patients and Providers Act. - Meetings regarding Medicare physician payment for 2024 and beyond.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2023
In Q2, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $20,000. The report was filed on July 19, 2023.
Original Filing: 301481667.xml
Lobbying Issues
FY 2024 Federal Funding for the National Institutes of Health, including the National Institute of Child Health and Human Development (NICHD) and the National Institute for Diabetes, Digestive and Kidney Diseases (NIDDK), Report Language Submissions regarding Precision Medicine and Urinary Incontinence and research connected to pregnancy and pelvic organ prolapse. - House and Senate Appropriations Committees.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 2474, the Strengthening Medicare for Patients and Providers Act. - Meetings regarding Medicare physician payment for 2024 and beyond.
Agencies Lobbied
U.S. Senate
1st Quarter, 2023
In Q1, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $20,000. The report was filed on April 17, 2023.
Original Filing: 301453488.xml
Lobbying Issues
FY 2024 Federal Funding for the National Institutes of Health, including the National Institute of Child Health and Human Development (NICHD) and the National Institute for Diabetes, Digestive and Kidney Diseases, Report Language Submissions regarding Precision Medicine and Urinary Incontinence and research connected to pregnancy and pelvic organ prolapse. - House and Senate Appropriations Committees.
Agencies Lobbied
U.S. Senate
Lobbying Issues
HR H.R. 2474, the Strengthening Medicare for Patients and Providers Act. - Meetings regarding Medicare physician payment for 2024 and beyond.
Agencies Lobbied
U.S. Senate
4th Quarter, 2022
In Q4, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $20,000. The report was filed on Jan. 19, 2023.
Original Filing: 301432170.xml
Lobbying Issues
FY 2023 Federal Funding for the National Institutes of Health, including the National Institute of Child Health and Human Development (NICHD) and the National Institute for Diabetes, Digestive and Kidney Diseases, Report Language Submissions regarding overactive bladder research and research connected to pregnancy and pelvic organ prolapse. - H.R.8295 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023
HR 2617 - Consolidated Appropriations Act of 2023 - FY 2023 NIH, NIDDK, NICHD, and NIA Funding
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 8800 - Supporting Medicare Providers Act of 2022 - Meetings and grassroots to gain co-sponsors for the legislation. HR 2617 - Consolidated Appropriations Act of 2023 - Medicare section on physician payment update for CY 2023 and CY 2024
Agencies Lobbied
U.S. Senate
3rd Quarter, 2022
In Q3, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $20,000. The report was filed on Oct. 17, 2022.
Original Filing: 301405252.xml
Lobbying Issues
FY 2023 Federal Funding for the National Institutes of Health, including the National Institute of Child Health and Human Development (NICHD) and the National Institute for Diabetes, Digestive and Kidney Diseases, Report Language Submissions regarding overactive bladder research and research connected to pregnancy and pelvic organ prolapse - H.R. 8295 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023
H.R. 6833 - Making Continuing Appropriations for FY 2023 and for other Purposes - Continued NIH Funding
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 8800 - Supporting Medicare Providers Act of 2022 - Meetings and grassroots to gain co-sponsors for the legislation
Agencies Lobbied
U.S. Senate
2nd Quarter, 2022
In Q2, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $10,000. The report was filed on July 20, 2022.
Original Filing: 301388399.xml
Lobbying Issues
FY 2023 Federal Funding for the National Institutes of Health, including the National Institute of Child Health and Human Development (NICHD) and the National Institute for Diabetes, Digestive and Kidney Diseases, Report Language Submissions regarding overactive bladder research and research connected to pregnancy and pelvic organ prolapse. - H.R.8295 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023
Agencies Lobbied
U.S. Senate
1st Quarter, 2022
In Q1, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $10,000. The report was filed on April 18, 2022.
Original Filing: 301359011.xml
Lobbying Issues
FY 2022 Federal funding for the National Institutes of Health, including the National Institute of Child Health and Human Development (NICHD) and the National Institute for Diabetes, Digestive and Kidney Diseases, Report Language Submissions regarding overactive bladder: FY2022 Consolidated Approps. Act (LHHSED, AG, E&W, FSGG, Int., MCVA, THUD) - HR 2471; H.R. 4502; FY 2023 Federal Funding for the National Institutes of Health, including the National Institute of Child Health and Human Development (NICHD) and the National Institute for Diabetes, Digestive and Kidney Diseases, Report Language Submissions regarding overactive bladder research and research connected to pregnancy and pelvic organ prolapse.
Agencies Lobbied
U.S. Senate
4th Quarter, 2021
In Q4, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $10,000. The report was filed on Jan. 16, 2022.
Original Filing: 301323602.xml
Lobbying Issues
FY 2022 Federal funding for the National Institutes of Health, including the National Institute of Child Health and Human Development (NICHD) and the National Institute for Diabetes, Digestive and Kidney Diseases, Report Language Submissions regarding overactive bladder: FY2022 Consolidated Approps. Act (LHHSED, AG, E&W, FSGG, Int., MCVA, THUD), H.R. 4502
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare Physician Fee Schedule Payments for 2022 - Update to the Conversion Factor, S. 610 Protecting Medicare and American Farmers from Sequester Cuts Act
Agencies Lobbied
U.S. Senate
3rd Quarter, 2021
In Q3, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $10,000. The report was filed on Oct. 20, 2021.
Original Filing: 301308748.xml
Lobbying Issues
FY 2022 Federal funding for the National Institutes of Health, including the National Institute of Child Health and Human Development (NICHD) and the National Institute for Diabetes, Digestive and Kidney Diseases, Report Language Submissions regarding overactive bladder: FY2022 Consolidated Approps. Act (LHHSED, AG, E&W, FSGG, Int., MCVA, THUD), H.R. 4502
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare Physician Fee Schedule Payments for 2022 - Update to the Conversion Factor
Medicare Proposed Physician Fee Schedule Payments for Office-based services - Clinical Labor Update, Reps. Rush and Bilirakis Letter to CMS, meetings with Members of the Ways and Means and Energy and Commerce Committees and Senate Finance Committee
Agencies Lobbied
U.S. Senate
2nd Quarter, 2021
In Q2, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $10,000. The report was filed on July 20, 2021.
Original Filing: 301291498.xml
Lobbying Issues
FY 2022 federal funding for the National Institutes of Health, including the National Institutes of Child Health and Human Development (NICHD) and the National Institutes for Diabetes, Digestive and Kidney Diseases; report language submissions regarding overactive bladder
Agencies Lobbied
U.S. Senate
Lobbying Issues
Medicare Physician Fee Schedule Payments for 2022 - Update to the Conversion Factor
Agencies Lobbied
U.S. Senate
1st Quarter, 2021
In Q1, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $10,000. The report was filed on April 20, 2021.
Original Filing: 301265607.xml
Lobbying Issues
-- FY 2022 federal funding for the National Institutes of Health, including the National Institutes of Child Health and Human Development (NICHD) and the National Institutes for Diabetes, Digestive and Kidney Diseases; report language submissions regarding overactive bladder
-- H.R. 1319 - American Rescue Plan Act of 2021: COVID-19 policies and funding
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 1868 - To prevent across-the-board direct spending cuts, and for other purposes: Extends a suspension of Medicare sequestration and makes other technical changes to Medicare payments and Medicaid eligibility
Agencies Lobbied
U.S. Senate
4th Quarter, 2020
In Q4, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $20,000. The report was filed on Jan. 20, 2021.
Original Filing: 301241167.xml
Lobbying Issues
H.R.133 - Consolidated Appropriations Act, 2021: FY 2021 federal funding for the National Institutes of Health, including the National Institute of Child Health and Human Development and the National Institute for Diabetes, Digestive, and Kidney Diseases; COVID-19 relief for physicians
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 8505 - To amend title XVIII of the Social Security Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare physician fee schedule, and for other purposes; H.R. 8702 / S. 5007 - Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020; H.R. 133 - Consolidated Appropriations Act, 2021: Addressing the impact of Evaluation and Management Services updates on the future of the conversion factor and the payments for other Medicare services; discussions of various policy change proposals to address the budget neutrality of these payment changes
Agencies Lobbied
U.S. Senate
3rd Quarter, 2020
In Q3, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $10,000. The report was filed on Oct. 19, 2020.
Original Filing: 301215950.xml
Lobbying Issues
-- H.R. 7614 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021: FY 2021 Federal funding for the National Institutes of Health, including the National Institute of Child Health and Human Development (NICHD) and the National Institute for Diabetes, Digestive, and Kidney Diseases.
Agencies Lobbied
U.S. Senate
Lobbying Issues
-- Addressing the impact of Evaluation and Management Services updates on the future of the conversion factor and the payments for other Medicare services; discussions of various policy change proposals to address the budget neutrality of these payment changes. H.R. 8505 - A bill to prevent pending Medicare payment cuts by waiving the budget neutrality requirements. Congressional letter to CMS and House leadership.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2020
In Q2, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $10,000. The report was filed on July 20, 2020.
Original Filing: 301197821.xml
Lobbying Issues
-- H.R. 7614 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2021: FY 2021 Federal funding for the National Institutes of Health, including the National Institute of Child Health and Human Development (NICHD) and the National Institute for Diabetes, Digestive, and Kidney Diseases.
-- H.R. 266 - Paycheck Protection Program and Health Care Enhancement Act; H.R. 6800 - The Heroes Act: COVID-19 policies and funding.
Agencies Lobbied
U.S. Senate
Lobbying Issues
-- Addressing the impact of Evaluation and Management Services updates on the future of the conversion factor and the payments for other Medicare services; discussions of various policy change proposals to address the budget neutrality of these payment changes.
Agencies Lobbied
U.S. Senate
1st Quarter, 2020
In Q1, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $10,000. The report was filed on April 20, 2020.
Original Filing: 301174541.xml
Lobbying Issues
-- FY 2021 Federal funding for the National Institutes of Health, including the National Institute of Child Health and Human Development (NICHD) and the National Institute for Diabetes, Digestive, and Kidney Diseases.
-- H.R. 748 / S. 3548 - CARES Act; H.R. 6201 - Family First Coronavirus Response Act; H.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020: COVID-19 Policies and Funding
Agencies Lobbied
U.S. Senate
4th Quarter, 2019
In Q4, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $10,000. The report was filed on Jan. 17, 2020.
Original Filing: 301110781.xml
Lobbying Issues
-- H.R. 1865 - FY 2020 Further Consolidated Appropriations Act (LHHSED, AG, Energy Water, Interior, Leg. Branch, MCVA, State-For. Ops, T-HUD): Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020: FY 2020 Federal funding for the National Institutes of Health, including the National Institute of Child Health and Human Development (NICHD) and the National Institute for Diabetes, Digestive, and Kidney Diseases.
Agencies Lobbied
U.S. Senate
Lobbying Issues
-- CY 2020 Proposed and Final Medicare Physician Fee Schedule: Proposal regarding global surgical packages and post-op visits payments.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2019
In Q3, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $10,000. The report was filed on Oct. 21, 2019.
Original Filing: 301073470.xml
Lobbying Issues
-- H.R. 2740 - Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020: FY 2020 Federal funding for the National Institutes of Health, including the National Institute of Child Health and Human Development (NICHD) and the National Institute for Diabetes, Digestive, and Kidney Diseases.
Agencies Lobbied
U.S. Senate
Lobbying Issues
-- CY 2020 Proposed and Final Physician Fee Schedule: Proposal regarding global surgical packages and post-op visits payments; obtain congressional letter to Centers for Medicare and Medicaid Services (CMS).
Agencies Lobbied
U.S. Senate
2nd Quarter, 2019
In Q2, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $10,000. The report was filed on July 22, 2019.
Original Filing: 301058843.xml
Lobbying Issues
-- H.R. 2740 - Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020: FY 2020 Federal funding for the National Institutes of Health, including the National Institute of Child Health and Human Development (NICHD) and the National Institute for Diabetes, Digestive, and Kidney Diseases.
Agencies Lobbied
U.S. Senate
1st Quarter, 2019
In Q1, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $10,000. The report was filed on April 22, 2019.
Original Filing: 301037880.xml
Lobbying Issues
-- FY 2020 Federal funding for the National Institutes of Health, including the National Institute of Child Health and Human Development (NICHD) and the National Institute for Diabetes, Digestive, and Kidney Diseases.
Agencies Lobbied
U.S. Senate
4th Quarter, 2018
In Q4, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $10,000. The report was filed on Jan. 22, 2019.
Original Filing: 301016901.xml
Lobbying Issues
-- CY 2019 Proposed Medicare Fee Schedule - Proposal regarding office visit documentation and payments; congressional letters to Centers for Medicare and Medicaid Services.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2018
In Q3, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $10,000. The report was filed on Oct. 19, 2018.
Original Filing: 300992503.xml
Lobbying Issues
-- H.R. 6740 / S. 3158 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019; H.R.6157 - Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019: Federal research funding for pelvic floor disorders at the National Institutes of Health, specifically the National Institute of Child Health and Human Development and the National Institute of Diabetes, Digestive, and Kidney Diseases.
Agencies Lobbied
U.S. Senate
Lobbying Issues
-- CY 2019 Proposed Medicare Fee Schedule - Proposal regarding office visit documentation and payments; congressional letters to Centers for Medicare and Medicaid Services.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2018
In Q2, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $10,000. The report was filed on July 20, 2018.
Original Filing: 300975235.xml
Lobbying Issues
-- House Subcommittee Draft / S. 3158: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019: Federal research funding for pelvic floor disorders at the National Institutes of Health, specifically the National Institute of Child Health and Human Development and the National Institute of Diabetes, Digestive, and Kidney Diseases.
Agencies Lobbied
U.S. Senate
1st Quarter, 2018
In Q1, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $10,000. The report was filed on April 19, 2018.
Original Filing: 300949939.xml
Lobbying Issues
-- H.R. 3358 / S. 1771 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018; H.R. 1892 - Continuing Resolution; H.R. 1625 - Vehicle for Consolidated Appropriations Act 2018: FY 2018 federal research funding for pelvic floor disorders at the National Institutes of Health, specifically the National Institute of Child Health and Human Development and the National Institute of Diabetes, Digestive, and Kidney Diseases.
Agencies Lobbied
U.S. Senate
Lobbying Issues
-- H.R. 1892 - Continuing Resolution: Changes to the Medicare Access and CHIP Reauthorization Act of 2016 regarding CMS flexibility for cost measures, penalties, Part B drugs, and PTAC
Agencies Lobbied
U.S. Senate
4th Quarter, 2017
In Q4, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $10,000. The report was filed on Jan. 22, 2018.
Original Filing: 300935747.xml
Lobbying Issues
-- H.R. 3358 / S. 1771 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018; H.J.Res. 123 / H.R. 13470 - Continuing Resolutions: FY 2018 federal research funding for pelvic floor disorders at the National Institutes of Health, specifically the National Institute of Child Health and Human Development and the National Institute of Diabetes, Digestive and Kidney Diseases.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2017
In Q3, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $10,000. The report was filed on Oct. 20, 2017.
Original Filing: 300914113.xml
Lobbying Issues
-- H.R. 3358 / S. 1771 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018: FY 2018 federal research funding for pelvic floor disorders at the National Institutes of Health, specifically the National Institute of Child Health and Human Development and the National Institute of Diabetes, Digestive and Kidney Diseases.
-- H.R. 1628 - American Health Care Act of 2017 / Senate Better Care Reconciliation Act of 2017: Essential benefits package, Medicaid expansion and coverage assistance.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2017
In Q2, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $10,000. The report was filed on July 20, 2017.
Original Filing: 300897702.xml
Lobbying Issues
-- Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018; FY 2018 federal research funding for pelvic floor disorders at the National Institutes of Health, specifically the National Institute of Child Health and Human Development and the National Institute of Diabetes, Digestive and Kidney Diseases.
-- H.R. 1628 - American Health Care Act of 2017 / Senate Better Care Reconciliation Act of 2017: Essential benefits package, Medicaid expansion and coverage assistance.
Agencies Lobbied
U.S. Senate
1st Quarter, 2017
In Q1, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $10,000. The report was filed on April 20, 2017.
Original Filing: 300873743.xml
Lobbying Issues
-- H.R. 5926 / S. 3040 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; H.R. 2028 - Further Continuing and Security Assistance Appropriations Act: FY 2017 federal research funding for pelvic floor disorders at the National Institutes of Health, specifically the National Institute of Child Health and Human Development and the National Institute of Diabetes, Digestive and Kidney Diseases.
-- H.R. 1628 - American Health Care Act of 2017: Essential benefits package, Medicaid expansion and coverage assistance.
Agencies Lobbied
U.S. Senate
4th Quarter, 2016
In Q4, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $10,000. The report was filed on Jan. 23, 2017.
Original Filing: 300857696.xml
Lobbying Issues
H.R. 5926 / S. 3040 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; H.R. 2028 - Further Continuing and Security Assistance Appropriations Act: FY 2017 federal research funding for pelvic floor disorders at the National Institutes of Health, specifically the National Institute of Child Health and Human Development and the National Institute of Diabetes, Digestive and Kidney Diseases.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015: Availability of resources for quality measures development included in the legislation; responses to Centers for Medicare & Medicaid Services requests for information regarding implementation.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2016
In Q3, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $10,000. The report was filed on Oct. 20, 2016.
Original Filing: 300835921.xml
Lobbying Issues
H.R. 5926 / S. 3040 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; H.R. 5325 - Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act: FY 2017 federal research funding for pelvic floor disorders at the National Institutes of Health, specifically the National Institute of Child Health and Human Development and the National Institute of Diabetes, Digestive and Kidney Diseases.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015: Availability of resources for quality measures development included in the legislation; responses to Centers for Medicare & Medicaid Services requests for information regarding implementation; discussion with Center for Medicare & Medicaid Innovation regarding development of alternative payment models.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2016
In Q2, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $10,000. The report was filed on July 20, 2016.
Original Filing: 300817973.xml
Lobbying Issues
House Committee Draft / S. 3040 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017: FY 2017 federal research funding for pelvic floor disorders at the National Institutes of Health, specifically the National Institute of Child Health and Human Development and the National Institute of Diabetes, Digestive and Kidney Diseases.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015: Availability of resources for quality measures development included in the legislation; comments in response to CMS proposed rule.
Agencies Lobbied
U.S. Senate
1st Quarter, 2016
In Q1, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $10,000. The report was filed on April 19, 2016.
Original Filing: 300794563.xml
Lobbying Issues
FY 2017 federal research funding for pelvic floor disorders at the National Institutes of Health, specifically the National Institute of Child Health and Human Development and the National Institute of Diabetes, Digestive and Kidney Diseases.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015: Availability of resources for quality measures development included in the legislation; comments in response to Request for Information from CMS.
Agencies Lobbied
U.S. Senate
4th Quarter, 2015
In Q4, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $10,000. The report was filed on Jan. 20, 2016.
Original Filing: 300784458.xml
Lobbying Issues
H.R. 2029 - Consolidated Appropriations Act, 2016: FY 2016 federal research funding for pelvic floor disorders at the National Institutes of Health, specifically the National Institute of Child Health and Human Development and the National Institute of Diabetes, Digestive and Kidney Diseases.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of H.R. 2 - Medicare Access and CHIP Reauthorization Act of 2015: Availability of resources for quality measures development included in the legislation; comments in response to Request for Information from CMS.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2015
In Q3, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $10,000. The report was filed on Oct. 20, 2015.
Original Filing: 300764214.xml
Lobbying Issues
FY 2016 federal research funding for pelvic floor disorders at the National Institutes of Health, specifically the National Institute of Child Health and Human Development and the National Institute of Diabetes, Digestive and Kidney Diseases.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Implementation of H.R.2 - Medicare Access and CHIP Reauthorization Act of 2015: Discussions regarding the resources for quality measures development included in the legislation.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2015
In Q2, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $10,000. The report was filed on July 19, 2015.
Original Filing: 300740324.xml
Lobbying Issues
FY 2016 federal research funding for pelvic floor disorders at the National Institutes of Health, specifically the National Institute of Child Health and Human Development and the National Institute of Diabetes, Digestive and Kidney Diseases.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R.2 - Medicare Access and CHIP Reauthorization Act of 2015: Halt the Medicare Physician Fee Schedule Final Rule provision to eliminate the 10- and 90-day global surgical packages, and repeal and replace the sustainable growth rate (SGR) with a new payment system.
Agencies Lobbied
U.S. Senate
1st Quarter, 2015
In Q1, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $10,000. The report was filed on April 20, 2015.
Original Filing: 300725493.xml
Lobbying Issues
FY 2016 federal research funding for pelvic floor disorders at the National Institutes of Health, specifically the National Institute of Child Health and Human Development and the National Institute of Diabetes, Digestive and Kidney Diseases.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R.2 - Medicare Access and CHIP Reauthorization Act of 2015: Halt the Medicare Physician Fee Schedule Final Rule provision to eliminate the 10- and 90-day global surgical packages, and repeal and replace the sustainable growth rate (SGR) with a new payment system.
Agencies Lobbied
U.S. Senate
4th Quarter, 2014
In Q4, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $10,000. The report was filed on Jan. 20, 2015.
Original Filing: 300707643.xml
Lobbying Issues
FY 2015 federal research funding for pelvic floor disorders at the National Institutes of Health, specifically at the National Institute of Child Health and Human Development and the National Institute of Diabetes, Digestive and Kidney Diseases.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R.83 - Consolidated and Further Continuing Appropriations Act, 2015: Halt the Medicare Physician Fee Schedule Final Rule provision to eliminate the 10- and 90-day global surgical packages.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2014
In Q3, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $10,000. The report was filed on Oct. 20, 2014.
Original Filing: 300683844.xml
Lobbying Issues
FY 2015 federal research funding for pelvic floor disorders at the National Institutes of Health, specifically at the National Institute of Child Health and Human Development and the National Institute of Diabetes, Digestive and Kidney Diseases.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 4015 / S. 2000 / S. 2110 / S. 2122 - SGR Repeal and Medicare Provider Payment Modernization Act of 2014: Legislation to replace the sustainable growth rate (SGR) formula and reform the Medicare Physician Payment.
Meetings to discuss the CY 2015 Proposed Medicare Physician Fee Schedule and the proposals regarding global surgical periods for Current Procedural Terminology (CPT) codes and the proposed changes to the quality reporting programs.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2014
In Q2, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $10,000. The report was filed on July 20, 2014.
Original Filing: 300663913.xml
Lobbying Issues
FY 2015 federal research funding for pelvic floor disorders at the National Institutes of Health, specifically at the National Institute of Child Health and Human Development and the National Institute of Diabetes, Digestive and Kidney Diseases.
Agencies Lobbied
U.S. Senate
Lobbying Issues
H.R. 4015 / S. 2000 / S. 2110 / S. 2122 - SGR Repeal and Medicare Provider Payment Modernization Act of 2014: Legislation to replace the sustainable growth rate (SGR) formula and reform the Medicare Physician Payment.
Agencies Lobbied
U.S. Senate
1st Quarter, 2014
In Q1, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $10,000. The report was filed on April 18, 2014.
Original Filing: 300641752.xml
Lobbying Issues
-- FY 2015 federal research funding for pelvic floor disorders at the National Institutes of Health, specifically at the National Institute of Child Health and Human Development and the National Institute of Diabetes, Digestive, and Kidney Diseases.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- H.R. 4015 / S. 2000 / S. 2110 / S. 2122: Legislation to replace the sustainable growth rate (SGR) formula and reform the Medicare Physician Payment.
-- H.R. 4302 - Protecting Access to Medicare Act of 2014: Legislation to halt Medicare cuts to physician payments for 12 months, until April 1, 2015.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2013
In Q4, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $10,000. The report was filed on Jan. 22, 2014.
Original Filing: 300628320.xml
Lobbying Issues
-- H.R. 3547 - Consolidated Appropriations Act, 2014: FY 2014 federal research funding for pelvic floor disorders at the National Institutes of Health, specifically at the National Institute of Child Health and Human Development and the National Institute of Diabetes, Digestive, and Kidney Diseases.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- H.R. 2810 - Medicare Patient Access and Quality Improvement Act of 2013 / S. __ - Original Bill to Repeal Sustainable Growth Rate System and to Consider Health Care Extenders: Legislation to replace the sustainable growth rate (SGR) formula and reform the Medicare Physician Payment.-- Senate Amendment to H.J. Res. 59 - Bipartisan Budget Act of 2013 and Pathway to SGR Reform Act of 2013: Legislation to address the SGR until March 31, 2014.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2013
In Q3, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society . The report was filed on Oct. 19, 2013.
Original Filing: 300601124.xml
Lobbying Issues
-- S. 1284 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2014: FY 2014 federal research funding for pelvic floor disorders at the National Institutes of Health, specifically at the National Institute of Child Health and Human Development and the National Institute of Diabetes, Digestive, and Kidney Diseases.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- Communications with relevant congressional committees regarding discussion drafts for legislation to replace the sustainable growth rate (SGR) formula and reform the Medicare Physician Payment.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2013
In Q2, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society , earning $10,000. The report was filed on July 22, 2013.
Original Filing: 300586268.xml
Lobbying Issues
-- S. 1284 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2014: FY 2014 federal research funding for pelvic floor disorders at the National Institutes of Health, specifically at the National Institute of Child Health and Human Development and the National Institute of Diabetes, Digestive, and Kidney Diseases.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
-- Communications with relevant congressional committees regarding discussion drafts for legislation to replace the sustainable growth rate (SGR) formula and reform the Medicare Physician Payment, and the future of Medicare Physician Payment.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2013
In Q1, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society . The report was filed on April 22, 2013.
Original Filing: 300564251.xml
Lobbying Issues
-- H.R. 933 - Consolidated and Further Continuing Appropriations Act, 2013: FY 2013 federal research funding for pelvic floor disorders at the National Institutes of Heath, specifically at the National Institute of Child Health and Human Development and the National Institute of Diabetes, Digestive, and Kidney Diseases.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2012
In Q4, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society . The report was filed on Jan. 22, 2013.
Original Filing: 300542837.xml
Lobbying Issues
-- S. 3295 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013: FY
2013 federal research funding for pelvic floor disorders at the National Institutes of Heath, specifically at the National Institute of
Child Health and Human Development and the National Institute of Diabetes, Digestive, and Kidney Diseases.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2012
In Q3, Galileo Consulting Group, Inc. lobbied for American Urogynecologic Society . The report was filed on Oct. 22, 2012.
Original Filing: 300520952.xml
Lobbying Issues
-- S. 3295 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013: FY 2013 federal research funding for pelvic floor disorders at the National Institutes of Heath, specifically at the National Institute of Child Health and Human Development and the National Institute of Diabetes, Digestive, and Kidney Diseases.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2012
Galileo Consulting Group, Inc. filed a lobbying registration on July 19, 2012 to represent American Urogynecologic Society, effective July 1, 2012.
Original Filing: 300494085.xml
Issue(s) they said they’d lobby about: -- Federal research funding for pelvic organ prolapse disease. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...